Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 13.90
+0.35 (2.58%)
At close: Mar 5, 2026
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 2.3 billion as of March 5, 2026. Its market cap has decreased by -16.02% in one year.
Market Cap
2.30B
Enterprise Value
2.56B
Revenue
44.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.90
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has increased from 1.15B to 2.30B, an increase of 100.13%. That is a compound annual growth rate of 4.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.25B | -42.20% |
| Dec 31, 2025 | 3.90B | 54.66% |
| Dec 31, 2024 | 2.52B | -54.81% |
| Dec 29, 2023 | 5.58B | -34.69% |
| Dec 30, 2022 | 8.55B | -50.08% |
| Dec 30, 2021 | 17.12B | 165.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LIWANLI Innovation | 3.35B |
| Merdury Biopharmaceutical | 3.32B |
| Maywufa Company | 2.90B |
| PhytoHealth | 2.73B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Allied Biotech | 2.54B |
| TSH Biopharm Corporation | 2.09B |
| GeneFerm Biotechnology | 1.71B |